Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 373.85 INR 2.06%
Market Cap: 46.1B INR
Have any thoughts about
Hikal Ltd?
Write Note

Hikal Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hikal Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Operating Income
â‚ą1.7B
CAGR 3-Years
-17%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
â‚ą66.3B
CAGR 3-Years
27%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
â‚ą56.2B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
â‚ą112.5B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
â‚ą27.8B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Income
â‚ą21.5B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hikal Ltd
Glance View

Market Cap
46.1B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
268.95 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Operating Income?
Operating Income
1.7B INR

Based on the financial report for Sep 30, 2024, Hikal Ltd's Operating Income amounts to 1.7B INR.

What is Hikal Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-4%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Hikal Ltd have been -17% over the past three years , -4% over the past five years .

Back to Top